Only adverse events related to hormonal effects and serious adverse events that occurred during chemotherapy with or without goserelin were routinely assessed, with assessment according to the Common ...
Goserelin is a gonadotropin-releasing hormone agonist for ovarian function suppression in the treatment of pre- and perimenopausal patients with breast cancer and for the preservation of ovarian ...
Genomic profiles in prostate cancer patients of varying measured socioeconomic inequality: A retrospective cohort study. Goserelin acetate extended-release microspheres for injection dosed every 4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results